Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research

Ravi Sarode, Nick Bandarenko, Mark E. Brecher, Joseph E. Kiss, Marisa B. Marques, Zbigniew M. Szczepiorkowski, Jeffrey L. Winters

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The American Society for Apheresis (ASFA) conducted a 1 day consensus conference on Thrombotic Thrombocytopenic Purpura (TTP) during its annual meeting in Atlanta, GA, on April 10, 2012. The authors of this article, a subcommittee of ASFA's Clinical Applications Committee, developed several questions with regard to definitions, classification, pathophysiology, diagnosis, management, and future research in TTP. These questions were provided to the seven invited speakers who are the experts in the field of TTP. Two moderators conducted the proceedings of the conference which was attended by more than 100 participants. After each presentation, there was an open discussion that included moderator-selected written questions submitted by the audience. A medical writer-generated transcript of the proceedings as well as each presentation was made available to the authors. Each summary was reviewed and approved by the respective speaker before submission of this article. The subcommittee also developed seven key questions for blinded, electronic polling conducted by the moderators to generate a consensus amongst the speakers. This article includes these presentation summaries as well as results of the electronic poll.

Original languageEnglish (US)
Pages (from-to)148-167
Number of pages20
JournalJournal of Clinical Apheresis
Volume29
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Thrombotic Thrombocytopenic Purpura

Keywords

  • ADAMTS13
  • microangiopathic hemolytic anemia
  • therapeutic plasma exchange
  • thrombotic thrombocytopenic purpura
  • Upshaw Shulman Syndrome

ASJC Scopus subject areas

  • Hematology

Cite this

Thrombotic thrombocytopenic purpura : 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. / Sarode, Ravi; Bandarenko, Nick; Brecher, Mark E.; Kiss, Joseph E.; Marques, Marisa B.; Szczepiorkowski, Zbigniew M.; Winters, Jeffrey L.

In: Journal of Clinical Apheresis, Vol. 29, No. 3, 2014, p. 148-167.

Research output: Contribution to journalArticle

Sarode, Ravi ; Bandarenko, Nick ; Brecher, Mark E. ; Kiss, Joseph E. ; Marques, Marisa B. ; Szczepiorkowski, Zbigniew M. ; Winters, Jeffrey L. / Thrombotic thrombocytopenic purpura : 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. In: Journal of Clinical Apheresis. 2014 ; Vol. 29, No. 3. pp. 148-167.
@article{c902e5f7ad644dad8f6c0eee4109a0bf,
title = "Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research",
abstract = "The American Society for Apheresis (ASFA) conducted a 1 day consensus conference on Thrombotic Thrombocytopenic Purpura (TTP) during its annual meeting in Atlanta, GA, on April 10, 2012. The authors of this article, a subcommittee of ASFA's Clinical Applications Committee, developed several questions with regard to definitions, classification, pathophysiology, diagnosis, management, and future research in TTP. These questions were provided to the seven invited speakers who are the experts in the field of TTP. Two moderators conducted the proceedings of the conference which was attended by more than 100 participants. After each presentation, there was an open discussion that included moderator-selected written questions submitted by the audience. A medical writer-generated transcript of the proceedings as well as each presentation was made available to the authors. Each summary was reviewed and approved by the respective speaker before submission of this article. The subcommittee also developed seven key questions for blinded, electronic polling conducted by the moderators to generate a consensus amongst the speakers. This article includes these presentation summaries as well as results of the electronic poll.",
keywords = "ADAMTS13, microangiopathic hemolytic anemia, therapeutic plasma exchange, thrombotic thrombocytopenic purpura, Upshaw Shulman Syndrome",
author = "Ravi Sarode and Nick Bandarenko and Brecher, {Mark E.} and Kiss, {Joseph E.} and Marques, {Marisa B.} and Szczepiorkowski, {Zbigniew M.} and Winters, {Jeffrey L.}",
year = "2014",
doi = "10.1002/jca.21302",
language = "English (US)",
volume = "29",
pages = "148--167",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Thrombotic thrombocytopenic purpura

T2 - 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research

AU - Sarode, Ravi

AU - Bandarenko, Nick

AU - Brecher, Mark E.

AU - Kiss, Joseph E.

AU - Marques, Marisa B.

AU - Szczepiorkowski, Zbigniew M.

AU - Winters, Jeffrey L.

PY - 2014

Y1 - 2014

N2 - The American Society for Apheresis (ASFA) conducted a 1 day consensus conference on Thrombotic Thrombocytopenic Purpura (TTP) during its annual meeting in Atlanta, GA, on April 10, 2012. The authors of this article, a subcommittee of ASFA's Clinical Applications Committee, developed several questions with regard to definitions, classification, pathophysiology, diagnosis, management, and future research in TTP. These questions were provided to the seven invited speakers who are the experts in the field of TTP. Two moderators conducted the proceedings of the conference which was attended by more than 100 participants. After each presentation, there was an open discussion that included moderator-selected written questions submitted by the audience. A medical writer-generated transcript of the proceedings as well as each presentation was made available to the authors. Each summary was reviewed and approved by the respective speaker before submission of this article. The subcommittee also developed seven key questions for blinded, electronic polling conducted by the moderators to generate a consensus amongst the speakers. This article includes these presentation summaries as well as results of the electronic poll.

AB - The American Society for Apheresis (ASFA) conducted a 1 day consensus conference on Thrombotic Thrombocytopenic Purpura (TTP) during its annual meeting in Atlanta, GA, on April 10, 2012. The authors of this article, a subcommittee of ASFA's Clinical Applications Committee, developed several questions with regard to definitions, classification, pathophysiology, diagnosis, management, and future research in TTP. These questions were provided to the seven invited speakers who are the experts in the field of TTP. Two moderators conducted the proceedings of the conference which was attended by more than 100 participants. After each presentation, there was an open discussion that included moderator-selected written questions submitted by the audience. A medical writer-generated transcript of the proceedings as well as each presentation was made available to the authors. Each summary was reviewed and approved by the respective speaker before submission of this article. The subcommittee also developed seven key questions for blinded, electronic polling conducted by the moderators to generate a consensus amongst the speakers. This article includes these presentation summaries as well as results of the electronic poll.

KW - ADAMTS13

KW - microangiopathic hemolytic anemia

KW - therapeutic plasma exchange

KW - thrombotic thrombocytopenic purpura

KW - Upshaw Shulman Syndrome

UR - http://www.scopus.com/inward/record.url?scp=84902529329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902529329&partnerID=8YFLogxK

U2 - 10.1002/jca.21302

DO - 10.1002/jca.21302

M3 - Article

C2 - 24136342

AN - SCOPUS:84902529329

VL - 29

SP - 148

EP - 167

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 3

ER -